Retraction notices · Reasons
Concerns/Issues about Results and/or Conclusions
- Percutaneous drainage for intraabdominal abscess in Crohn’s disease1/24/2022 0:00
- Do we take sufficient care of the quality of life in IBD patients in remission1/24/2022 0:00
- Second line agents are effective after failure of thiopurines in ulcerative colitis1/24/2022 0:00
- Azathioprine side effects in chronic inflammatory bowel disease treatment1/24/2022 0:00
- Adalimumab in Crohn’s disease: Relationship between intestinal symptoms and extraintestinal manifestations1/24/2022 0:00
- Increasing incidence of inflammatory bowel disease in Finland1/24/2022 0:00
- Pregnancy outcome in women with inflammatory bowel disease: A prospective European case-control ECCO EpiCom study1/24/2022 0:00
- Determination of alexithymia in inflammatory bowel disease patients1/24/2022 0:00
- NOD2, IL23R and ATG16L1 association analysis with inflammatory bowel disease in the Lithuanian population1/24/2022 0:00
- Incidence and early disease course of ulcerative colitis in Western Hungary between 2002 and 20061/24/2022 0:00
- miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer3/7/2022 0:00
- Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize12/14/2013 0:00
- Prevalence and risk factors of inflammatory articular manifestations in a Swiss cohort of inflammatory bowel disease patients1/24/2022 0:00
- Pouch-vaginal fistulas after restorative proctocolectomy for ulcerative colitis treatment options and outcome1/24/2022 0:00
- The visual word form area is organized according to orthography2/1/2014 0:00
- Prevalence of irritable bowel syndrome in first-degree relatives of patients with inflammatory bowel disease1/24/2022 0:00
- How do IBD patients search for information on their disease? Findings within a national clinical cohort study1/24/2022 0:00
- Prevalence of extraintestinal manifestation in inflammatory bowel disease according to the Hungarian pediatric IBD Registry (HUPIR)1/24/2022 0:00
- IBD and microscopic colitis in Uppsala health care region, a prospective epidemiological study of incidence, medical, and surgical treatment1/24/2022 0:00
- Epidemiological prospective study in inflamatory bowel disease in Aljarafe region (Seville)1/24/2022 0:00
- Factors influencing the use of immunosuppressive therapies during the early course of disease in patients with IBD Results of a population-based cohort1/24/2022 0:00
- Lymphoma risk in inflammatory bowel disease patients in a Dutch nationwide study1/24/2022 0:00
- High annual increase in the incidence of pediatric inflammatory bowel disease in Finland, 1987 2003, a nationwide study1/24/2022 0:00
- IBD in the elderly population, prevalence and disease course in Western Hungary between 1977 and 20081/24/2022 0:00
- Clinical outcome of Crohn’s disease diagnosed in the elderly1/24/2022 0:00
- Prediction of severe Cohn’s disease in a Spanish cohort1/24/2022 0:00
- Prevalence and natural history of hepatitis B and C infection in a population of Italian inflammatory bowel disease patients treated with anti-tumor necrosis factor-a agents1/24/2022 0:00
- Prevalence of anemia, iron status and erythropoiesis biomarkers in Greek patients with inflammatory bowel disease1/24/2022 0:00
- Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center1/24/2022 0:00
- Epidemiological aspects of IBD in the western part of Romania1/24/2022 0:00
- Clinical burden of two chronic conditions in university hospital setting: Inflammatory bowel disease and chronic liver disease1/24/2022 0:00
- Prevalence and associated factors in hepatitis B and C virus infection in patients with inflammatory bowel disease1/24/2022 0:00
- Inflammatory bowel disease in Pontevedra, northwest of Spain: Higher incidence and prevalence than previously reported1/24/2022 0:00
- Intestinal mucosal gene expression of endothelial cell adhesion molecules in patients with inflammatory bowel disease and the impact of infliximab therapy1/24/2022 0:00
- Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype, but do not predict it. Results from the IBDchip European project1/24/2022 0:00
- NKX2 3 rs10883365 is associated with disease susceptibility to IBD while IRGM rs13361189 is associated to Crohn’s disease in Eastern European patients1/24/2022 0:00
- Contribution of NKX2 3, PPTN22 and TNFSF15 genes variants to IBD predisposition in Italian population1/24/2022 0:00
- Haptoglobin polymorphisms are associated with ulcerative colitis and Crohn’s disease1/24/2022 0:00
- Two independent associations on the IBD5 locus with Crohn’s disease in the Czech population1/24/2022 0:00
- Investigation of Crohn’s disease associated loci in ulcerative colitis points towards common susceptibility genes in the Th17 pathway and innate inmunity1/24/2022 0:00
- Disease phenotype, surgery and medical therapy in monozygotic British twins with inflammatory bowel disease1/24/2022 0:00
- Association of TNF and FCGR3A gene polymorphisms with differential response to anti-TNF agents in inflammatory bowel disease1/24/2022 0:00
- Association of peroxisome proliferator-activated receptor-gamma polymorphisms in Lithuanian patients with inflammatory bowel disease1/24/2022 0:00
- Contribution of IL23R and ATG16L and NOD2 to Crohn’s disease risk in a Mediterranean area1/24/2022 0:00
- Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis2/5/2022 0:00
- Blockade of adherent-invasive E. coli replication within macrophages: A novel mechanism of infliximab1/24/2022 0:00
- Expression of human CEACAM6 in transgenic mice increases intestinal permeability and favours AIEC translocation1/24/2022 0:00
- Role of meprins to protect the gut mucosa from colonization by adherent-invasive E. coli1/24/2022 0:00
- Subclinical intestinal dysbiosis in unaffected relatives of Crohn’s disease patients1/24/2022 0:00
- The impact of anti-tumour necrosis factor-alpha (TNF-a) treatment on faecal microbiota in inflammatory bowel disease (IBD)1/24/2022 0:00